NanoViricides
NNVC
$1.11
Share price
1.13%
Change (1 day)
-16.37%
Change (1 year)
Categories
NanoViricides (NNVC) - Cash on Hand
Cash on Hand as of December 2023 : $5.24 M
According to NanoViricides's latest financial reports the company has $5.24 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
NanoViricides - Cash on Hand chart (from 2006 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $8.14 M | -42.06% |
| 2022-06-30 | $14.06 M | -31.44% |
| 2021-06-30 | $20.51 M | 49.66% |
| 2020-06-30 | $13.7 M | 436.5% |
| 2019-06-30 | $2.55 M | -63.92% |
| 2018-06-30 | $7.08 M | -53.1% |
| 2017-06-30 | $15.09 M | -37.51% |
| 2016-06-30 | $24.16 M | -23.22% |
| 2015-06-30 | $31.46 M | -14.25% |
| 2014-06-30 | $36.69 M | 163.57% |
| 2013-06-30 | $13.92 M | -2.46% |
| 2012-06-30 | $14.27 M | 54.76% |
| 2011-06-30 | $9.22 M | 32.61% |
| 2010-06-30 | $6.95 M | 311.72% |
| 2009-06-30 | $1.68 M | 106.94% |
| 2008-06-30 | $0.81 M | -15.64% |
| 2007-06-30 | $0.96 M | -61.4% |
| 2006-06-30 | $2.5 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $7.26 B | 138,384.03% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 135,124.02% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $9.67 B | 184,253.06% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | 121,051.03% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | 10,738.22% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.38 B | 7,315.82% | 🇺🇸 USA |